Positive effects of a novel non-peptidyl low molecular weight radical scavenger in renal ischemia/reperfusion: a preliminary report by Bassi, Roberto et al.
 
Positive effects of a novel non-peptidyl low molecular weight
radical scavenger in renal ischemia/reperfusion: a preliminary
report
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Bassi, Roberto, Andrea Vergani, Francesca D’Addio, Moufida
Ben Nasr, Alessio Mocci, Maria Pia Rastaldi, Takaharu
Ichimura, Joseph Vincent Bonventre, and Paolo Fiorina. 2014.
“Positive effects of a novel non-peptidyl low molecular weight
radical scavenger in renal ischemia/reperfusion: a preliminary
report.” SpringerPlus 3 (1): 158. doi:10.1186/2193-1801-3-158.
http://dx.doi.org/10.1186/2193-1801-3-158.
Published Version doi:10.1186/2193-1801-3-158
Accessed February 19, 2015 3:56:24 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:12152917
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAASHORT REPORT Open Access
Positive effects of a novel non-peptidyl low
molecular weight radical scavenger in renal
ischemia/reperfusion: a preliminary report
Roberto Bassi
1,2,3, Andrea Vergani
1, Francesca D’Addio
1,3, Moufida Ben Nasr
1, Alessio Mocci
1,4, Maria Pia Rastaldi
5,
Takaharu Ichimura
6, Joseph Vincent Bonventre
6 and Paolo Fiorina
1,3,6*
Abstract
Ischemia/reperfusion (I/R) is one of the most common causes of acute kidney injury. Reactive oxygen species have been
recognized to be an important contributor to the pathogenesis of I/R injury. We hypothesize that a non-peptidyl low
molecular weight radical scavenger (IAC) therapy may counteract this factor, ultimately providing some protection after
acute phase renal I/R injury. The aim of this preliminary study was to assess the ability of IAC to reduce acute
kidney injury in C57BL/6 mice after 30-minute of bilateral ischemia followed by reperfusion. The rise in serum
creatinine level was higher in C57BL/6 control mice after I/R when compared to IAC (1 mg)-treated mice. Control
mice showed greater body weight loss compared to IAC-treated mice, and at pathology, reduced signs of tubular
necrosis were also evident in IAC-treated mice. These preliminary evidences lay the basis for more comprehensive
studies on the positive effects of IAC as a complementary therapeutic approach for acute phase renal I/R injury.
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Introduction
Kidney global or regional ischemia/reperfusion (I/R) is
one of the most common causes of acute kidney injury
(McCord 1985). During the peritransplant period, kidney
transplanted patients are prone in 2-7% of the cases to
experience I/R (Bonventre and Yang 2011), which can
render the allograft more likely to develop acute rejec-
tion, and to progress towards long-term chronic allograft
nephropathy (Thadhani et al. 1996; Cavaille-Coll et al.
2013). I/R injury is also a common event in a variety of
pathological conditions such as diabetes and cardiovas-
cular diseases (Luitse et al. 2012). Tissue hypoperfusion/
hypoxia leads to depletion of cellular ATP and cytoskel-
eton damage (Singh et al. 2013). The restoration of
blood flow with production of reactive oxygen species
(ROS), and activation of leukocytes and endothelial cells
(Rabb 2012; Ko et al. 2011) contribute to reperfusion
injury. Although many experimental studies show a
decreased injury and preserved renal function after
dampening ROS production, efficient treatments are
still limited (Cavaille-Coll et al. 2013; Leung et al.
2013; Venturini et al. 2006; Fiorina et al. 2006). Cur-
rently, the therapy for I/R injury is mainly based on
supportive care and fluid administration (Cavaille-Coll
et al. 2013; Luitse et al. 2012; Fiorina et al. 2005, 2006)
and I/R injury remains a major cause of morbidity and
mortality (Cavaille-Coll et al. 2013; Luitse et al. 2012;
Fiorina et al. 2005, 2006). Non-peptidyl low molecular
weight radical scavenger (IAC), a clinically available
drug (D’Aleo et al. 2009), has been shown to have anti-
oxidant properties in different models of brain and
islet induced ischemia (D’Aleo et al. 2009; Corsi et al.
2011). We studied the effect of a IAC-based therapy in
a murine model of bilateral kidney I/R injury, aiming
to establish a proof-of-concept for the use of IAC as
novel complementary therapy for individuals at risk for
renal acute ischemic injuries.
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Animals
C57BL/6 (H-2Kb) mice were obtained from Jackson La-
boratory (Bar Harbor, ME) and were housed in a pathogen-
free environment; water and chow diet were provided ad
libitum. Control (CTRL) and IAC-treated mice were weight
(~20 grams), sex (male) and age (10 weeks-old) matched.
Mice were cared for in accordance with institutional guide-
lines at the Harvard Medical School Facilities for Animal
Care and Housing. Protocols were approved by the Har-
vard Animal Care and Use Committee.
Interventional and functional studies
Two groups of C57BL/6 mice (n=10 each) were subjected
to experimental kidney ischemia through bilateral simul-
taneous clamping of vascular pedicles for 30 minutes,
followed by clamp removal to allow kidney reperfusion.
Mice were then treated with a single intraperitoneal injec-
tion of IAC (1 mg) or saline solution at 60 minutes after
ischemic injury induction (30 minutes after clamps re-
moval). Blood samples were collected by retro-orbital vein
puncture before kidney ischemia induction (baseline; BL)
at day (D)1, D2 and D4. Renal function was assessed by
serum creatinine measurement by Creatinine Reagent Kit
(Pointe Scientific, Lincoln Park, MI). Mouse weight was
measured using a Pesola Digital Platform Scale (Pesola
AG, Baar, Switzerland). IAC was kindly provided by
Medestea Research and Production (Turin, Italy).
Murine kidney pathology
Bilateral nephrectomy was performed at D4 in three mice
per group for histological evaluation and acute tubular ne-
crosis score computation (Fiorina et al. 2006). Kidney tis-
sue was placed in 10% buffered formalin followed by
paraffin embedding for haematoxylin and eosin staining.
Histological slides for renal tissue damage evaluation, were
examined by the operator without knowledge of the ex-
perimental design.
Statistical analysis
Data are expressed as mean ± SD. Unpaired t-test was
used to compare difference between groups. Statistical
significance was set as p value < 0.05. Analysis of data
was performed using STATA v12 statistical package for
Windows (StataCorp, TX, USA).
Results
Our preliminary results show that treatment with a sin-
gle dose of IAC (1 mg) reduces kidney injuries in
C57BL/6 mice during the first two days (acute phase) of
experimentally induced bilateral I/R injury. In the un-
treated group (CTRL), one animal died after 48 hours,
Figure 1 IAC treatment partially prevented serum creatinine levels increase, body weight loss and acute tubular necrosis after I/R
induction. (A) Untreated control (CTRL) mice showed at day (D) 1 and D2 a more significant increase in serum creatinine levels after the
induction of ischemia/reperfusion compared to non-peptidyl low molecular weight radical scavenger (IAC)-treated mice (D1 and D2: CTRL vs.
IAC-treated, *p < 0.05). (B) Untreated CTRL mice showed a progressive and more evident reduction of body weight after ischemia/reperfusion in-
duction compared to IAC-treated mice (D1, D2 and D4: CTRL vs. IAC-treated, *p < 0.05). (C) Untreated CTRL mice showed acute tubular necrosis
signs in kidneys outer medulla with hyaline and granular casts accumulation. (D) Conversely, the extent of acute tubular necrosis was reduced in
IAC-treated mice.
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not shown). The mouse from the CTRL group that did
not survive, showed the highest serum creatinine value
(2.60 mg/dl at D1). We intentionally used an interven-
tional protocol for I/R with a low mortality rate, to gain
better insight on the effect of IAC on kidney function ra-
ther than on a survival effect.
At baseline, serum creatinine levels were similar be-
tween CTRL and IAC-treated mice (BL: CTRL = 0.30 ±
0.40 vs. IAC-treated =0.22 ± 0.30 mg/dl, p =ns), however
a rapid increase in serum creatinine was observed in
both groups soon after kidney I/R (Figure 1A). Serum
creatinine levels in CTRL mice were significantly
higher at D1 and D2 when compared to levels ob-
served in IAC (1 mg)-treated mice (D1: CTRL=1.59 ±
0.17 vs. IAC-treated=1.31±0.19 mg/dl, p=0.02; D2:
CTRL=1.02±0.21 vs. IAC-treated=0.79±0.13 mg/dl,
p=0.01), (Figure 1A). At D4 serum creatinine levels
showed no difference between CTRL and IAC-treated
mice, (D4: CTRL=0.71±0.13 vs. IAC-treated=0.57±
0.10 mg/dl, p=ns), (Figure 1A).
Body weight was comparable between CTRL and
IAC-treated mice at baseline (BL: CTRL = 24.1 ±0.2 vs.
IAC-treated =24.9 ±0.4 gr, p= ns), (Figure 1B). CTRL
mice showed a progressive and more significant reduc-
tion of body mass during the follow-up period as com-
pared to IAC-treated mice (D1: CTRL =22.5± 0.2 vs.
IAC-treated =23.4 ±0.3 gr, p=0.02; D2: CTRL =21.8 ±
0.1 vs. IAC-treated =22.7 ±0.3 gr, p =0.02; D4: CTRL =
20.8 ±0.2 vs. IAC-treated =22.2± 0.4 gr, p= 0.01),
(Figure 1B).
We finally examined the extent of kidney damage at
D4 post I/R induction, particularly acute tubular necro-
sis (a hallmark of I/R injury). In CTRL mice, acute tubu-
lar necrosis was preferentially localized to the outer
medulla of kidneys, with evident amounts of hyaline and
granular casts (Figure 1C). In contrast, at D4 after I/R
induction, in IAC-treated mice a marked reduction of
acute tubular necrosis was evident as compared to un-
treated CTRL mice (Figure 1D). No signs of acute tubu-
lar necrosis were detectable in kidneys of sham-operated
animals (data not shown).
Discussion
I/R injury is an important contributor in acute kidney
injury (Thadhani et al. 1996). After the ischemic event,
organ reperfusion is accompanied by a cascade of in-
flammatory responses boosted by the local recruitment
of peripheral leukocytes and the release of ROS (Rabb
2012). Together they lead to a common downstream
pathway that results in the activation of pro-apoptotic
genes such as caspase-3 and ultimately to acute kidney
injury (Yang et al. 2005). Moreover, oxidative stress, oc-
curring when ROS generation exceeds the capacity of
anti-oxidant defenses, may cause indiscriminate damage
to lipids, proteins and DNA, leading to future cell dys-
function and tissue damage (Yang et al. 2005). We here
showed that non-peptidyl low molecular weight radical
scavenger treatment, prevented serum creatinine in-
crease, body weight loss and kidney tubular damage in
C57BL/6 mice in the first two days after experimental
kidney I/R injury. Thus, our preliminary results suggest
that a non-peptidyl low molecular weight radical scaven-
ger, having anti-oxidant properties, may warrant consid-
eration as a complementary therapeutic strategy for the
treatment of acute phase renal I/R injury in kidney
transplanted patients (possibly reducing the risk for im-
mediate acute rejection after transplant) or in individuals
at risk for oxidative stress-related organ/tissue damage.
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